Use of indigestible oligosaccharides to reduce the incidence of otitis
media in humans
    10.
    发明授权
    Use of indigestible oligosaccharides to reduce the incidence of otitis media in humans 失效
    使用消化不良的寡糖来减少人体中耳炎的发病率

    公开(公告)号:US5849324A

    公开(公告)日:1998-12-15

    申请号:US653083

    申请日:1996-06-12

    摘要: A method is provided for reducing the incidence of otitis media in infants and young children by enterally administering indigestible fructooligosaccharides. More specifically, the present invention relates to a method for reducing the incidence of otitis media comprising administering to humans an indigestible fructooligosaccharide selected from the group consisting of 1-kestose, nystose and 1-.sup.F -B-fructofuranosyl nystose . The indigestible fructooligosaccharides can be produced through enzymatic synthesis, chemical techniques or isolated from plant materials and are administered in the form of a nutritional product, candy, tablets, chewing gums, lozenges, milk products, yogurts and the like. In a preferred embodiment of this invention, the fructooligosaccharides have a DP of 2 to 20 and still more preferably are the fructooligosaccharides FG.sub.2, GF.sub.3, and GF.sub.4.

    摘要翻译: 提供一种通过肠内施用难消化的低聚果糖来减少婴幼儿中耳炎发生率的方法。 更具体地说,本发明涉及一种降低中耳炎发生率的方法,其包括向人体施用选自1-睾酮,蔗糖和1-F-B-呋喃果糖基半胱氨酸的消化不良的低聚果糖。 难消化的低聚果糖可以通过酶合成,化学技术或从植物材料中分离来制备,并以营养产品,糖果,片剂,口香糖,锭剂,乳制品,酸奶等的形式给药。 在本发明的优选实施方式中,低聚果糖的DP为2〜20,进一步优选为低聚果糖FG2,GF3,GF4。